SPEECH BIOMARKERS IN HEREDITARY SPASTIC PARAPLEGIA
Objective: To evaluate the frequency and clinical characterization of dysarthria in different types of HSP. Background: Hereditary spastic paraplegias (HSP) are a group of genetic…EVALUATION OF MOTOR SPEECH DISORDERS IN PATIENTS WITH PARKINSON’S DISEASES.
Objective: To correlate auditory-perceptual assessment and the patient self-perception in speech disorders in Parkison’s Disease and correlate them with clinical data.To correlate auditory-perceptual assessment and…Clinical presentation of Wilson’s disease in pediatric and adult patients: A systematic review
Objective: To identify the most frequent signs and symptoms in Wilson's disease comparing between pediatric and adult patients. Background: Wilson's disease or Progressive Lenticular Degeneration…Multimodal Conversational AI for Remote Patient Monitoring and Analysis of Parkinson’s Disease
Objective: To present, analyze and evaluate a cloud-based audio-visual dialog agent and its associated automated speech, face and movement analytics for remote patient monitoring in…Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)
Objective: Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD. Background: Disordered speech…Increased Syllable Duration as a Marker for Dysarthria in Essential Tremor Patients with Deep Brain Stimulation
Objective: To establish phonetic parameters that enable objectivation and measurability of stimulation-induced dysarthria (SID) in essential tremor (ET) patients with deep brain stimulation (DBS) in…The Unique Voiceprint Changed In Parkinson’s Disease
Objective: To discover the unique voiceprint changed in patients with Parkinson’s disease. Background: Parkinson’s disease, PD, is a serious neurodegenerative disease affected millions old people…Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance
Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…Measurement of speech as a biomarker of neurodegenerative disease using acoustic profiles and machine learning
Objective: To examine the utility of speech biometrics for describing and delineating neurodegenerative diseases using acoustic measures and machine learning procedures. Background: Progressive neurological disorders…Are oromotor deficits a late stage signs in Parkinson’s disease?
Objective: To assess any preclinical signs of dysphagia in early PD. Background: Pre-clinical stages of Parkinson’s disease (PD) include the subtle signs of autonomic dysfunction,…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 16
- Next Page »